Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

treatment   source : Ir.ateapharma.com    save search

Atea Pharmaceuticals Announces U.S. FDA Fast Track Designation Granted to Bemnifosbuvir, an Investigational Oral Antiviral, for the Treatment of COVID-19
Published: 2023-04-25 (Crawled : 11:00) - ir.ateapharma.com
AVIR | $3.71 0.0% 270K twitter stocktwits trandingview |
Health Technology
| | O: 0.62% H: 2.74% C: 1.86%

covid-19 fda granted treatment pharmaceuticals designation fast track designation
New Data Showcasing Favorable Profile of Bemnifosbuvir for Treatment of COVID-19 and Hepatitis C to be Presented at 2023 International Conference on Antiviral Research
Published: 2023-03-08 (Crawled : 12:00) - ir.ateapharma.com
AVIR | $3.71 0.0% 270K twitter stocktwits trandingview |
Health Technology
| | O: 0.3% H: 2.98% C: 1.79%

covid-19 treatment hepatitis research conference bemnifosbuvir antiviral favorable international
Atea Pharmaceuticals Announces First Patient Dosed in SUNRISE-3 Phase 3 Registrational Trial of Bemnifosbuvir, an Investigational Oral Antiviral for the Treatment of COVID-19
Published: 2022-11-29 (Crawled : 12:00) - ir.ateapharma.com
AVIR | $3.71 0.0% 270K twitter stocktwits trandingview |
Health Technology
| | O: -1.53% H: 4.0% C: 1.78%

covid-19 treatment pharmaceuticals antiviral trial
Atea Pharmaceuticals Presents Favorable AT-752 Phase 1 Data for Treatment of Dengue Fever at American Society of Tropical Medicine & Hygiene 2022 Annual Meeting
Published: 2022-11-03 (Crawled : 11:00) - ir.ateapharma.com
AVIR | $3.71 0.0% 270K twitter stocktwits trandingview |
Health Technology
| | O: 0.85% H: 3.19% C: 1.68%

at-752 treatment pharmaceuticals meeting dengue phase 1
Atea Pharmaceuticals Announces U.S. FDA Fast Track Designation Granted to AT-752 for Treatment of Dengue
Published: 2022-09-26 (Crawled : 11:00) - ir.ateapharma.com
AVIR | $3.71 0.0% 270K twitter stocktwits trandingview |
Health Technology
| | O: -0.52% H: 6.07% C: -4.68%

at-752 treatment fda pharmaceuticals designation granted qdengue fast track designation
Gainers vs Losers
64% 36%

Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M twitter stocktwits trandingview |
Finance

ZCMD | $2.86 108.76% 52.1% 2.3M twitter stocktwits trandingview |
Commercial Services

INVO | $1.555 104.6% 51.13% 5M twitter stocktwits trandingview |
Health Technology

ISPC | $0.437 105.16% 49.53% 37M twitter stocktwits trandingview |
Professional, Scientific, and T...

WLGS | News | $0.92 84.0% 45.65% 1.6M twitter stocktwits trandingview |

OST | $0.499 21.38% 45.26% 1.9M twitter stocktwits trandingview |

XPON | News | $3.1 60.62% 37.74% 17M twitter stocktwits trandingview |

TIRX | $0.7 44.39% 30.74% 58M twitter stocktwits trandingview |

BNTC | News | $6.92 44.17% 30.64% 3.5M twitter stocktwits trandingview |
Health Technology

GGE | $0.035 19.86% 29.3% 64M twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.